We are live on ! Find out more
DBTX

Decibel Therapeutics, Inc. Common Stock
DBTX

Delisted

DBTX was delisted on the 22nd of September, 2023.

Back to rankings

40 hedge funds and large institutions have $81.7M invested in Decibel Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

11% more funds holding

Funds holding: 36 → 40 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

44% less capital invested

Capital invested by funds: $146M → $81.7M (-$64.2M)

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

Holders
40
Holders Change
+4
Holders Change %
+11.11%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
3
Reduced
12
Closed
6
Calls
$482K
Puts
–
Net Calls
+$482K
Net Calls Change
+$482K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$350K
2
Two Sigma Investments
Two Sigma Investments
New York
+$326K
3
MAM
Marquette Asset Management
Minnesota
+$127K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$117K
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$110K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.99M
2
FCMI
Foresite Capital Management IV
California
-$2.29M
3
CS
Credit Suisse
Switzerland
-$1.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.17M
5
AA
AlphaCentric Advisors
Puerto Rico
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$73K – – –
Federated Hermes
27
Federated Hermes
Pennsylvania
$70K – – –
LCM
28
Laurion Capital Management
New York
$70K – – –
Northern Trust
29
Northern Trust
Illinois
$67K -$6.88K -1,000 -7%
Bank of America
30
Bank of America
North Carolina
$64K -$38.2K -5,550 -29%
Morgan Stanley
31
Morgan Stanley
New York
$62K -$103K -14,892 -53%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$53K +$77.8K +11,300 New
FHA
33
Flagship Harbor Advisors
Massachusetts
$47K +$69.6K +10,113 New
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
$19K +$29.5K +4,283 New
Optiver Holding
35
Optiver Holding
Netherlands
$7K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$7K +$9.7K +1,409 New
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$5K -$6.88K -1,000 -48%
Citigroup
38
Citigroup
New York
$3K +$5.17K +751 New
FCG
39
Financial Connections Group
California
$1K +$2.06K +300 New
FCMI
40
Foresite Capital Management IV
California
– -$2.29M -297,711 Closed
CS
41
Credit Suisse
Switzerland
– -$1.94M -251,950 Closed
AA
42
AlphaCentric Advisors
Puerto Rico
– -$289K -37,500 Closed
E
43
Ergoteles
New York
– -$154K -19,968 Closed
UBS Group
44
UBS Group
Switzerland
– +$654 +95 New
1
2

DBTX Hedge Fund Activity: Q4 2021 in Review

40 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q4 2021, worth a combined $81.7M — down 44% from $146M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DBTX positions and 6 closed out — a net gain of 4 holders — while 3 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $350K. The largest seller was BlackRock, cutting an estimated $4.99M.

  • 40 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q4 2021, up from 36 in Q3 2021.
  • Funds reported $81.7M of Decibel Therapeutics, Inc. Common Stock stock for Q4 2021, down 44% quarter-over-quarter.
  • 10 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q4 2021 and 6 closed out, a net change of +4 holders.
  • The largest Decibel Therapeutics, Inc. Common Stock buyer in Q4 2021 was Renaissance Technologies, an estimated $350K added.
  • The largest Decibel Therapeutics, Inc. Common Stock seller in Q4 2021 was BlackRock, an estimated $4.99M sold.

Based on aggregated 13F filings for Q4 2021.